Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine
29 March 2017
NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:
- NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
- NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
- For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
- Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.
Documents to download